H
Hoth Therapeutics, Inc. (HOTH)
NCM – Real vaqt narxi. Valyuta: USD
0.66
-0.00 (-0.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.65
-0.01 (-1.50%)
Bozor oldidan: May 13, 2026, 8:23 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.66
-0.00 (-0.03%)
Yopilishda: May 12, 2026, 4:00 PM EDT
0.65
-0.01 (-1.50%)
Bozor oldidan: May 13, 2026, 8:23 AM EDT
Hoth Therapeutics, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda tibbiy ehtiyojlarni qondirish uchun terapiyalarni ishlab chiqishga qaratilgan. U HT-001 ni ishlab chiqadi, bu tirazinkinoza epidermal o'sish omilining retseptor inhibitori terapiyasining boshlang'ich va takroriy kurslari bilan bog'liq toshma va teri kasalliklari bilan og'rigan bemorlarni davolash uchun II bosqichli klinik tadqiqotda bo'lgan mahalliy formuladir; HT-KIT mast hujayralaridan kelib chiqqan saraton va anafilaksiyani davolash uchun; HT-TBI travmatik miya shikastlanishi va ishemik insultni davolash uchun; HT-ALZ Altsgeymer yoki boshqa neyroinflamatuar kasalliklarni davolash va/yoki oldini olish uchun; va HT-004 astma va allergiyani inhalatsion ma'muriyatdan foydalangan holda davolash uchun. Kompaniya ekzemani davolash uchun I bosqichli klinik tadqiqotda bo'lgan o'ziga xos, patentlangan, dorivor birikma platformasi bo'lgan BioLexa Platformasini ishlab chiqmoqda; va HT-005 bemorlarda lupusni davolash uchun. Kompaniya Jorj Vashington universiteti; Isoprene Pharmaceuticals, Inc.; Shimoliy Karolina shtat universiteti; Chelexa BioSciences, Inc. va Cincinnati universiteti; Zylö Therapeutics, Inc.; va Voltron Therapeutics, Inc. bilan litsenzion shartnomalarga ega. Kompaniya 2017 yilda tashkil etilgan va Xoboken, Nyu-Jersi shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. David S. Briones | Chief Financial Officer |
| Mr. Robb Knie | Founder, President, CEO & Chairman |
| Ms. Hayley Springer | Executive Vice President of Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 8-K | ea0289520-8k_hoth.htm |
| 2026-05-04 | 8-K | ea0288939-8k_hoth.htm |
| 2026-04-16 | 8-K | ea0286719-8k_hoth.htm |
| 2026-03-27 | 10-K | ea0279196-10k_hoth.htm |
| 2026-01-16 | 8-K | ea0272968-8k_hoth.htm |
| 2025-12-02 | CORRESP | filename1.htm |
| 2025-11-17 | S-3 | ea0264829-s3_hoth.htm |
| 2025-11-12 | 10-Q | ea0262611-10q_hoth.htm |
| 2025-10-17 | 8-K | ea0261354-8k_hoth.htm |
| 2025-09-12 | 8-K | ea0257020-8k_hoth.htm |